Studies of Heparin Binding to Antithrombin III by Crossed Immunoelectrophoresis

Summary

The technique of crossed immunoelectrophoresis has been used to study the binding to purified antithrombin III (At III) of heparin and other mucopolysaccharides. The technique was unable to detect differences among samples of whole heparin from various manufacturers, but proved useful in studying the binding of heparin fractions; at the same molarities, low and high molecular weight heparin fractions displayed equal binding ability to At III. A semi-synthetic heparin analogue showed no evidence of binding to At III, but a sample of heparan sulphate did interact with At III at a concentration 3 times that of heparin. Samples of purified At III from four different manufacturers all displayed heterogeneity with respect to heparin binding. A proportion of the total At III did not bind to heparin and, in one sample, this non-binding material constituted about 40% of the total. An antiserum made against purified At III contained antibodies with different cross-reactivities against heparin bound and non-heparin bound At III.

• References

• 1 Andersson L-O, Barrowcliffe TW, Holmer E, Johnson EA, Sims GE C. 1976; Anticoagulant properties of heparin fractionated by affinity chromatography on matrix bound antithrombin III and by gel filtration. Thrombosis Research 9: 575
• 2 Andersson L-O, Engman L, Henningsson E. 1977; Crossed immunoelectrophoresis as applied to studies on complex formation. The binding of heparin to antithrombin III and the antithrombin III-thrombin complex Journal of Immunological Methods 14: 271
• 3 Barrowcliffe TW, Johnson EA, Eggleton CA, Thomas DP. 1978; Anticoagulant activities of lung and mucous heparins. Thrombosis Research 12: 27
• 4 Barrowcliffe TW, Johnson EA, Eggleton CA, Kemball-Cook G, Thomas DP. 1979; Anticoagulant activities of high and low molecular weight heparin fractions. British Journal of Haematology 41: 573
• 5 Biggs R, Denson KW E, Akman N, Borrett R, Haddon M. 1970; Antithrombin III, antifactor Xa, and heparin. British Journal of Haematology 19: 283
• 6 Campbell PJ. 1974; International Biological Standards and Reference Preparations II. Procedures used for the Production of Biological Standards and Reference Preparations. Journal of Biological Standardisation. Vol 2 p 259
• 7 Johnson EA, Kirkwood TB L, Stirling Y, Perez-Requejo JL, Ingram GI C, Bangham DR, Brozovic M. 1976; Four heparin preparations: anti-Xa potentiating effect of heparin after subcutaneous injection. Thrombosis and Haemostasis 35: 586
• 8 Johnson EA, Mulloy B. 1976; The molecular weight range of mucosal heparin preparations. Carbohydrate Research 51: 119
• 9 Kakkar VV, Lawrence D, Bentley PG, De Haas HA, Ward VP, Scully MF. 1978; A comparative study of low doses of heparin and a heparin analogue in the prevention of postoperative deep vein thrombosis. Thrombosis Research 13: 111
• 10 Laurell CB. 1966; Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analytical Biochemistry 15: 45
• 11 Lowry CH, Rosebrough NJ, Farr AL, Randall RJ. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 256
• 12 Miller-Andersson M, Borg H, Andersson L-O. 1974; Purification of antithrombin III by affinity chromatography. Thrombosis Research 5: 439
• 13 Pepper DS, Banhegyi D, Cash JD. 1977; The different forms of antithrombin III in serum. Thrombosis and Haemostasis 38: 494
• 14 Sas G, Pepper DS, Cash JD. 1975; Investigations on antithrombin III in normal plasma and serum. British Journal of Haematology 30: 265
• 15 Shearn SA M, Giddings JC, Peake IR, Bloom AL. 1974; A comparison of five different rabbit antisera to factor VIII and the demonstration of a factor VIII related antigen in normal and von Willebrand’s disease platelets. Thrombosis Research 5: 585
• 16 Schipper HG, Jenkins CS P, Kahlé LH, Ten Cate JW. 1978; Antithrombin III transfusion in disseminated intravascular coagulation. Lancet 1: 854
• 17 Thomas DP, Barrowcliffe TW, Kirkwood TB L. An international collaborative assay of antithrombin III. Thrombosis and Haemostasis 43: 1
• 18 Thomas DP, Merton RH. 1978. Biological standardisation of mucopolysaccharides. Proceedings of 5th International Congress on Thromboembolism; Bologna:
• 19 Thomas DP, Merton RH, Barrowcliffe TW, Mulloy B, Johnson EA. 1979 Antifactor Xa activity of heparan sulphate. Thrombosis Research. (in press)
• 20 Williams L, Murano G. 1978. Antithrombin III heterogeneity. Proceedings of 17th Congress of the International Society of Haematology; Paris: 254 (Abstract).